New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may significantly reduce the risk of atrial fibrillation (AF) returning, offering patients a simple, low-cost way to support long-term heart health. The study, published this month in the Journal of Interventional Cardiac Electrophysiology, found that adults who engaged in regular, … Read more
SAN DIEGO — Same-day discharge after ablation of atrial fibrillation (AF) is an appropriate strategy for saving costs if performed with strict selection criteria and protocols, according to a recently issued joint statement from the American College of Cardiology and the Heart Rhythm Society. Same-day discharge has long been indicated for catheter ablations to abort … Read more
TOPLINE: The combination of remimazolam and ketamine for deep analgosedation during pulsed-field ablation for atrial fibrillation was associated with fewer adverse events than propofol-based methods, with the regimen significantly reducing hypoxemia and hypotension. METHODOLOGY: Czech researchers conducted a prospective randomized controlled trial involving 127 patients (mean age, 62.9 years; 35.1% women) with an indication for … Read more
TOPLINE: Aggressive ablation provided more favorable outcomes at 12 months than regular ablation in patients with persistent atrial fibrillation (AF). Patients undergoing aggressive ablation also had enhanced AF and atrial tachycardia (AT)–free survival. METHODOLOGY: Previous studies suggest using aggressive ablation for persistent AF, but real-world evidence with the approach is lacking. Researchers conducted a retrospective … Read more
TOPLINE: The occurrence of acute brain lesions was lower with a transseptal puncture than with a conventional retrograde aortic approach in patients undergoing left ventricular catheter ablation, with no significant difference in the safety or efficacy profile between both approaches. METHODOLOGY: Previous studies suggested that catheter ablation for atrial fibrillation results in new brain lesions … Read more
MADRID, December 19, 2024–(BUSINESS WIRE)–“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm the success of ablation under direct vision in real time” Peter Hinchliffe, CEO MedLumics The results of this clinical investigation will be presented in Boston at … Read more